4Rosenthal VD, Maki DG, Mehta Y ,et o/.International Noso- comial Infection Control Consortium (INICC)report, data summary of 43 countries for 2007-2012.Device-associated module[J].Am J Infect Control, 2014,42 (9) : 942-956.
5Tacconelli E.Screening and isolation for infection control [J].J Hosp Infect,2009,5(2) : 1-7.
6Horan TC, Andrus M, Dudeck MA, et al. CDC/NHSN sur- veillance definition of healthcare-associated infection and crite- ria for specific types of infections in the acute care setting[J]. Am J Infect Control, 2008 , 36(5) :309- 332.
7Mermel LA, Allon M, Bouza E, et al. Clinical practice guide- lines for the diagnosis and management of intravascular cathe- ter-related infection: 2009 Update by the Infectious Diseases Society of America EJ]. Clin Infect Dis, 2009, 49(1) : 1 - 45.
8Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-re- sistant, extensively drug-resistant and pandrug-resistant bacte- ria: an international expert proposal for interim standard defi- nitions for acquired resistanceEJ]. Clin Microbiol Infect, 2012, 18(3) :268 - 281.
9O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections[J]. Am J Infect Control, 2011 , 39(4 Suppl 1) :$1 - 834.
10Siegel JD, Rhinehart E, Jackson M, et al. Management ofmultidrug-resistant organisms in health care settings, 2006 [J]. Am J Infect Control, 2007, 35(10 Suppl 2):S165 - S193.
